Quell Therapeutics
Cell and Gene
Quell Therapeutics is a UK based private biopharmaceutical company. Its vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
See other Cell and Gene organisations
-
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting clonal neoantigens: protein markers unique to the individual ... -
Aglaris Ltd produce equipment to ensure cell and tissue culture is an easy, problem-free task. -
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London ... -
The Cell and Gene Therapy Catapult was established in 2012 as an independent centre of excellence to advance…
Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.
Learn moreCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.